Narrative review / 2016
Cancer cachexia involves systemic metabolic deregulation and tissue wasting that supports tumor growth and directly causes at least 20% of cancer deaths.
This review describes cancer cachexia as a systemic metabolic syndrome wherein tumor growth is supported by tissue wasting and metabolite mobilization. Cachexia causes unstoppable loss of skeletal muscle and fat storage despite adequate caloric intake, leading to nutrient mobilization directly as lipids and amino acids and indirectly as glucose from liver gluconeogenesis. Metabolic dysfunctions include increased insulin and IGF-1 resistance, mitochondrial uncoupling, and fat browning, and cachexia is estimated to be the direct cause of at least 20% of cancer deaths.
- Study type
- Narrative review
- Who was studied
- Cancer patients with cachexia
- What was measured
- Metabolic deregulation, tissue wasting, nutrient mobilization, and mortality in cancer cachexia
THE PAPER
Understanding cachexia as a cancer metabolism syndrome.
Porporato PE. Oncogenesis, 2016.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.